Literature DB >> 2211711

Defined geometry of binding between triantennary glycopeptide and the asialoglycoprotein receptor of rat heptocytes.

K G Rice1, O A Weisz, T Barthel, R T Lee, Y C Lee.   

Abstract

Three derivatives of a triantennary glycopeptide, each containing a single uniquely located 6-amino-galactose residue at either position 6', 6, or 8, were modified at the 6-amino group by attachment of a photolyzable reagent and radiolabeled by iodination of tyrosine. These were allowed to bind to the asialoglycoprotein receptor of isolated rat hepatocytes and photolyzed for affinity labeling. (formula; see text) Each probe specifically labeled either the major (RHL1) or minor (RHL2/3) subunits which comprise the receptor. A photolyzable group attached to galactose residue 6 6' specifically radiolabeled RHL1, whereas a photolyzable group attached to galactose 8 specifically labeled RHL2/3. Photoaffinity labeling of a soluble rat hepatic lectin preparation demonstrated that the minor subunits (RHL2/3) were no longer labeled by the triantennary probe with a photolyzable group at galactose 8. The inhibitory potency of a variety of complex glycopeptides against radiolabeled ligand binding to both rat hepatocytes and soluble lectin are in agreement with photoaffinity results that galactose 8 of triantennary glycopeptide is of unique importance by binding solely to the minor subunits (RHL2/3) of the asialoglycoprotein receptor on hepatocytes. Conversely, galactose residues 6 and 6' bind specifically to the major subunit (RHL1), indicating a precise binding geometry between the trivalent ligand and lectin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211711

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Affinity enhancement by multivalent lectin-carbohydrate interaction.

Authors:  R T Lee; Y C Lee
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

2.  Ligands of the asialoglycoprotein receptor for targeted gene delivery, part 1: Synthesis of and binding studies with biotinylated cluster glycosides containing N-acetylgalactosamine.

Authors:  Ulrika Westerlind; Jacob Westman; Elisabeth Törnquist; C I Edvard Smith; Stefan Oscarson; Martina Lahmann; Thomas Norberg
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

3.  Hepatocyte adhesion to carbohydrate-derivatized surfaces. I. Surface topography of the rat hepatic lectin.

Authors:  O A Weisz; R L Schnaar
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

4.  Photoaffinity probes for studying carbohydrate biology.

Authors:  Seok-Ho Yu; Amberlyn M Wands; Jennifer J Kohler
Journal:  J Carbohydr Chem       Date:  2012-07-02       Impact factor: 1.667

5.  Determinants of oligomeric structure in the chicken liver glycoprotein receptor.

Authors:  F Verrey; K Drickamer
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

6.  Systemic absorption and activity of recombinant consensus interferons after intratracheal instillation and aerosol administration.

Authors:  R W Niven; K L Whitcomb; M Woodward; J Liu; C Jornacion
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

7.  Two categories of mammalian galactose-binding receptors distinguished by glycan array profiling.

Authors:  Peter J Coombs; Maureen E Taylor; Kurt Drickamer
Journal:  Glycobiology       Date:  2006-05-02       Impact factor: 4.313

Review 8.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

Review 9.  Physical approaches for nucleic acid delivery to liver.

Authors:  Kenya Kamimura; Dexi Liu
Journal:  AAPS J       Date:  2008-12-13       Impact factor: 4.009

10.  Differential flexibilities in three branches of an N-linked triantennary glycopeptide.

Authors:  P G Wu; K G Rice; L Brand; Y C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.